CeriBell, Inc (CBLL) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of CeriBell, Inc stock $19.06, price $26.42, that is 27.9% below the price, quality 41 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
CeriBell, Inc
CBLL · USExpensive (fair value 28% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
25‑month range $10.92 – $30.24 · fair‑value band $14.29 – $23.82 · the $26.42 price screens above the $19.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Every Wednesday you see whether CeriBell is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
Show moreShow less
The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.
In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Stock analysis
CeriBell, Inc (CBLL) currently trades at $26.42, while our estimate is $19.06, 28% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $14.29 (bear) to $23.82 (bull), the price of $26.42 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
CeriBell, Inc reported revenue of $89.1M in FY2025 versus $25.9M in FY2022, a compound +50.9%/yr. Reported net income was −$53.4M in FY2025.
Key figures
Market cap $1.0B Small · P/S ratio 9.86 · EPS (TTM) $−1.95 · Net margin −68.0% · Return on equity −52.5% · Return on assets (EBIT) −35.0% (4-year average) · Operating margin −70.0% · Revenue (TTM) $109M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 7% below its 52-week high and 105% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at −28%, CBLL screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, 7 officers or directors sold shares worth $7.8M and none bought.
- SaleWilliam W BurkeDirector3× since Dec 9, 2025: 52,935 shares, avg. $23.50$1.2MNov 12, 202610b5-1 plan
- SaleJoseph Michael TaylorDirector3× since Jun 11, 2026: 28,795 shares, avg. $23.80$685,322Nov 9, 2026
- SaleRaymond WooChief Technology Officer12× since Dec 1, 2025: 82,950 shares, avg. $19.86$1.6MNov 2, 2026
- SaleScott BlumbergChief Financial Officer7× since Dec 22, 2025: 75,716 shares, avg. $22.91$1.7MSep 15, 2026
- SaleXingjuan ChaoPresident and CEO, Director17× since Nov 21, 2025: 560,182 shares, avg. $19.86$11.1MSep 15, 2026
- SaleDavid FoehrSenior VP, Finance and PAO8× since Dec 3, 2025: 35,243 shares, avg. $20.89$736,176Sep 8, 202610b5-1 plan
- SaleJoseph S. ManniChief Revenue Officer3× since Feb 23, 2026: 3,507 shares, avg. $20.73$72,694Aug 21, 2026
- SaleJames G CoulterFormer 10% Owner202,368 shares at $20.12$4.1MJun 26, 2026
- SaleRebecca B RobertsonDirector4× since Dec 2, 2025: 9,154 shares, avg. $20.02$183,232Mar 3, 202610b5-1 plan
- SaleJosef ParviziDirector5× since Dec 8, 2025: 100,000 shares, avg. $21.22$2.1MFeb 19, 202610b5-1 plan
Plus 21 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
CBLL screens overvalued: fair value 28% below the price. Compare with Abbott Laboratories, →
Compare CeriBell, Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs CBLL |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs CBLL |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs CBLL |
| STERIS plc STE | $261.91 | $281.90 | +8% | vs CBLL |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥184.30 | ¥197.34 | +7% | vs CBLL |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs CBLL |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs CBLL |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs CBLL |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs CBLL |
| Koninklijke Philips N.V PHIA | €27.54 | €15.23 | −45% | vs CBLL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CeriBell, Inc (CBLL) overvalued or undervalued?
What is the fair value of CBLL?
What is the quality score of CBLL?
What is the price target for CeriBell, Inc (CBLL)?
What is the CeriBell, Inc stock forecast for 2026?
What is the revenue of CeriBell, Inc (CBLL)?
What is the intrinsic value of CeriBell, Inc (CBLL)?
Is CeriBell, Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of CBLL?
How much is CeriBell, Inc worth?
What do the bullish and bearish scenarios say about CBLL?
How solid is the balance sheet of CeriBell, Inc (CBLL)?
How far is CBLL from its 52-week high?
Which stocks are comparable to CeriBell, Inc?
Is CeriBell, Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of CeriBell, Inc (CBLL)?
What should I pay attention to with CeriBell, Inc right now?
Key figures of CeriBell, Inc
How large is the market capitalisation of CeriBell, Inc (CBLL)?
What is the P/S ratio of CeriBell, Inc (CBLL)?
What are the earnings per share of CeriBell, Inc (CBLL)?
What is the net margin of CeriBell, Inc (CBLL)?
What is the return on equity of CeriBell, Inc (CBLL)?
What is the EBIT return on assets of CeriBell, Inc (CBLL)?
What is the operating margin of CeriBell, Inc (CBLL)?
How fast is revenue growing at CeriBell, Inc (CBLL)?
How much free cash flow does CeriBell, Inc (CBLL) generate?
How much net cash does CeriBell, Inc (CBLL) hold?
Watch CeriBell, Inc in the live analysis
One click puts CeriBell, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.